Advertisement
Journal Home
Search for

Volume 45, Issue 1, Pages 23-27 (January 2003)


View previous. 6 of 12 View next.

Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis

Katherine K. HsuabCorresponding Author Informationemail address, Stephen I. Peltonab, Daniel S. Shapiroac

Received 28 January 2002; accepted 19 August 2002.

Abstract 

The diagnostic value of negative blood cultures from neonates whose mothers receive intrapartum antimicrobial prophylaxis for prevention of perinatal group B streptococcal disease is uncertain. We investigated whether blood culture medium containing resin designed to adsorb antibiotic improved group B streptococcal detection following simulated intrapartum antimicrobial prophylaxis. Group B streptococcus (Streptococcus agalactiae) was preincubated with varying antibiotic concentrations before inoculation into BACTEC Peds Plus resin-containing medium, BACTEC Standard, or Trek ESP 80A. In the presence of 10 mcg/mL ampicillin, detection of both low (<500 CFU/mL) and high (>500 CFU/mL) S. agalactiae inocula ranged between 75-100% of resin-containing medium bottles; detection rates in both non-resin-containing media were lower. When S. agalactiae was detected, it was detected sooner with resin-containing medium. The addition of gentamicin to ampicillin did not affect sensitivity of resin-containing medium for S. agalactiae. In our model, resin-containing medium more consistently and more rapidly detected S. agalactiae than did either of two non-resin-containing media, in the presence of antibiotic levels likely present in fetal sera following intrapartum antimicrobial prophylaxis.

a Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA

b Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA

c Departments of Medicine and Pathology and Laboratory Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA

Corresponding Author InformationCorresponding author. Tel.: +1-617-414-6394; fax: +1-617-414-7230.

PII: S0732-8893(02)00480-7

doi:10.1016/S0732-8893(02)00480-7


View previous. 6 of 12 View next.

Advertisement